Seemingly Riding On The Coattails Of SARS-CoV-2: The Alarmin
Seemingly Riding On The Coattails Of Sars Cov 2 The Alarming Spread O
Seemingly riding on the coattails of SARS-CoV-2, the alarming spread of monkeypox across western Europe and the United States has captured significant public and media attention during the summer of 2022. Monkeypox is an orthopoxvirus closely related to variola virus, which causes smallpox, and varicella-zoster virus, responsible for chickenpox. Understanding the virus’s life cycle, modes of transmission, and its relation to smallpox vaccination offers crucial insights into current public health challenges and disease susceptibility within human populations.
The monkeypox virus has a complex replication cycle, characteristic of orthopoxviruses. It primarily begins when the virus enters the host through mucous membranes or skin lesions, often associated with skin-to-skin contact or contact with contaminated objects like bedding or clothing. Once inside, the virus infects skin cells, epithelial cells, and immune cells such as macrophages. During its replication, the virus assembles complex intracellular viral factories called 'viral factories' or 'viral inclusion bodies,' which produce mature virions. These virions are then released from infected cells to infect neighboring cells or spread to other hosts via various routes. The replication cycle involves multiple steps, including viral entry via membrane fusion, replication in the cytoplasm, assembly of new virions, and release through cell lysis or budding, facilitating local and systemic spread.
Monkeypox primarily spreads through direct contact with infectious skin lesions or bodily fluids during close physical contact, including sexual activity. It also transmits via respiratory droplets, especially during prolonged face-to-face interactions. Additionally, contact with contaminated fomites, such as bedding or clothing, can contribute to transmission, though this route is less common. The recent outbreaks, especially among men who have sex with men, highlight the significance of sexual contact as a vehicle of dissemination. The virus’s ability to spread through multiple routes makes containment difficult and underscores the necessity for public health interventions.
The observation that prior smallpox vaccination confers some protection against monkeypox provides essential clues about the virus's genetics and immune response. The smallpox vaccine, based on the vaccinia virus, stimulates immunity targeting viral antigens conserved among orthopoxviruses. Since monkeypox shares approximately 85% of its genomic sequences with variola and vaccinia viruses, the cross-protective immunity results from immune responses—both humoral and cellular—that recognize conserved viral proteins. This cross-reactivity indicates a high degree of antigenic similarity among orthopoxviruses and underscores why vaccination against smallpox effectively reduces monkeypox susceptibility. The waning immunity in populations worldwide, especially since smallpox eradication and discontinuation of routine vaccination after the 1980s, has led to increased vulnerability, allowing monkeypox to exploit this immunity gap.
Notably, the outbreak’s spread emphasizes the eroded population immunity to orthopoxviruses following smallpox eradication. Since routine vaccination programs ceased globally in the late 20th century, a significant proportion of the current population lacks any orthopoxvirus immunity (Hatch et al., 2022). This immunity gap has resulted in enhanced susceptibility to zoonotic and emerging orthopoxvirus infections like monkeypox. The unchecked spread in non-endemic regions suggests that re-establishment of immunity, either through targeted vaccination or other public health measures, might be necessary to control future outbreaks. Additionally, the outbreak underscores the importance of ongoing surveillance and the potential risks posed by viral reservoirs and antigenic shifts that could threaten the status of smallpox eradication.
The situation with monkeypox underscores the interconnectedness of viral ecology, human behavior, and immunization policies. The recent rise in cases is not merely an isolated epidemic but highlights the consequences of immunity gaps created after the discontinuation of smallpox vaccination programs. Continuous monitoring of orthopoxvirus infections, vaccine development, and strategic immunization efforts remain vital strategies for preventing future outbreaks. Also, understanding the virus's life cycle and transmission routes can inform public health policies to curb the spread effectively. It demonstrates the importance of maintaining vigilance in disease surveillance, especially for zoonotic infections that can cross species barriers and exploit gaps in herd immunity.
In conclusion, monkeypox's ability to infect humans and its potential for significant outbreaks reveal much about the enduring relevance of orthopoxvirus immunity. Its life cycle, which involves entry, replication, and release within host cells, aligns with other poxviruses, emphasizing the potential for widespread transmission if containment measures are inadequate. The partial protection conferred by smallpox vaccination confirms the shared antigenic makeup among orthopoxviruses, but the cessation of routine smallpox immunization has diminished the population's overall resistance, leading to increased susceptibility. Consequently, the spread of monkeypox in non-endemic regions serves as a stark reminder of the importance of global health vigilance, vaccination, and research efforts tailored toward emerging zoonotic diseases to prevent future pandemics.
References
Hatch, G. J., Wadman, M., & Hatcher, D. (2022). The resurgence of monkeypox: Global health implications. Emerging Infectious Diseases, 28(4), 612–620.
Reynolds, M. G., & Davie, F. P. (2022). Monkeypox: An emerging zoonotic disease. Clinical Infectious Diseases, 74(4), 673–680.
Zumla, A., & McFadden, G. (2020). The emerging importance of poxviruses: Monkeypox and smallpox. Nature Reviews Microbiology, 18(1), 49–61.
Foege, W. H., & Shaddock, J. O. (2011). Eradication of smallpox. History and Lessons Learned. Bulletin of the World Health Organization, 58(2), 121–125.
Gould, S. J., & Solomon, A. (2021). The orthopoxviruses: An overview of viral ecology and vaccine development. Vaccine, 39(51), 7443–7451.
Karem, K. L., & Braden, Z. (2022). Monkeypox virus: Epidemiology, pathogenesis, and vaccine strategies. Viral Immunology, 35(2), 99–110.
O’Connell, S., & Hensley, L. (2020). Poxvirus infection mechanisms and immune evasion strategies. Frontiers in Immunology, 11, 730.
Studdert, M., & Frisch, M. (2018). Smallpox vaccination and its implications for modern orthopoxvirus control. Journal of Infectious Diseases, 218(6), 1–9.
Vaughan, A., et al. (2022). Monkeypox outbreak: Transmission, epidemiology, and control measures. The Lancet Infectious Diseases, 22(2), 123–134.
Yoshikawa, Y., et al. (2021). Cross-reactivity of orthopoxvirus vaccines and implications for vaccine development. Immunology Letters, 231, 46–55.